2.
不同TNM分期局限期SCLC近期及远期疗效比较
Comparison of short-term and long-term effect in different TNM stage in limited-disease SCLC
| TNM | N | CR | PR | SD | PD | RR (%) | Median PFS (mo) | Median OS (mo) (95%CI) |
| TNM:the TNM (Tumor, Node, Metastasis) stage of lung cancer; CR:complete response; PR:partial response; SD:stable disease; PD:progressive disease; RR:response rate; PFS:progression-free survival. | ||||||||
| Stage Ⅰ | 17 | 8 | 9 | 0 | 0 | 100 | 22.0 | 30.3 |
| Stage Ⅱ | 15 | 4 | 10 | 1 | 0 | 93.3 | 15.9 | 22.1 |
| Stage Ⅲa | 41 | 14 | 22 | 3 | 2 | 87.8 | 11.9 | 16.0 |
| Stage Ⅲb期 | 18 | 6 | 12 | 0 | 0 | 100 | 10.5 | 15.3 |